Selsun

Selsun is a medicated hair-care brand best known for anti-dandruff shampoos and scalp treatments. Its core identity is built around clinically established anti-dandruff ingredients, especially selenium sulfide, a topical active used to control dandruff, seborrheic dermatitis symptoms and related scalp flaking. In Indonesia, the brand is operated and marketed by PT Rohto Laboratories Indonesia, part of Japan’s Rohto Pharmaceutical group. The local portfolio includes several shampoo and scalp-care lines, including Selsun Yellow, Selsun Gold, Selsun Blue, Selsun Blue 5, Selsun Yellow Double Impact, Selsun 7 Flowers, Selsun 7 Herbal, newer Scalp Care products, a hairfall-control serum and conditioner products. Rohto’s Indonesian website presents Selsun as a specialist anti-dandruff range containing selenium sulfide in core products, while some newer scalp-care products use other active or functional ingredients. The broader Selsun brand history is generally traced to the United States, where Selsun was introduced as a prescription anti-dandruff product in 1953 and later expanded into over-the-counter use. Selsun Blue was introduced as an over-the-counter medicated shampoo in 1974, with a widely recognized 1% selenium-sulfide formulation. The product name is associated with selenium sulfide, the active ingredient that helped distinguish the brand from mainstream cosmetic shampoos. Prescription-strength and market-specific formulations have also used higher concentrations, including 2.5% selenium sulfide in some products and markets. Selsun’s commercial positioning differs by market. In North America, Selsun Blue has been developed as a consumer-health brand offering medicated, moisturizing, 2-in-1 and other dandruff-care formats. Corporate filings from Chattem described the brand as having been acquired from Abbott Laboratories in 2002 and then supported through product, packaging, advertising, media and distribution investment. Chattem was later acquired by Sanofi in 2010. The North American consumer-health portfolio subsequently became part of Opella, which became an independent company in 2025. In other markets, including Indonesia and several Asian countries, Selsun is associated with Rohto Pharmaceutical and is distributed through Rohto’s local operating companies. In Indonesia, Selsun is positioned as a specialist scalp-health brand rather than an ordinary daily shampoo. The local range addresses different consumer needs, including oily scalp, visible dandruff, sensitive or dry hair, hair fall, freshness, hair manageability and conditioning. Product naming uses color, number and benefit cues: Yellow is associated with stronger medicated dandruff care; Blue and Blue 5 emphasize broader scalp and hair-care benefits; Gold, 7 Flowers and 7 Herbal extend the range toward cosmetic care, fragrance and botanical positioning. Rohto also markets Selsun Scalp Care Purifying Shampoo, which uses piroctone olamine, climbazole and additional scalp-conditioning ingredients rather than relying solely on the traditional selenium-sulfide proposition. The brand has a strong Asian footprint. Rohto states that Selsun enjoys particularly strong popularity across Asia, and the Indonesian subsidiary sells the range through pharmacies, health and beauty retailers, cosmetic stores and official online marketplaces. The brand is active in both therapeutic and mass-market channels, combining medicated efficacy with cosmetic features such as moisturizers, botanical ingredients, fragrance, shine, softness and easier hair management. Selsun has also faced a significant Indonesian product-safety incident. In 2026, PT Rohto Laboratories Indonesia announced that Selsun 7 Flowers and Selsun 7 Herbal were withdrawn after differing laboratory results concerning 1,4-dioxane contamination. The company said more than 96% of the affected products had been withdrawn, that the affected formulas were being reformulated and that relaunch was planned for the second half of 2026, subject to regulatory requirements. Rohto stated that other Selsun shampoo variants were not affected according to its announcement. This event is an important part of the brand’s current history and should be distinguished from the wider Selsun portfolio.

Selsun’s documented history begins in the United States in the early 1950s. The brand was launched in 1953 as a prescription anti-dandruff shampoo. Its central active ingredient was selenium sulfide, a selenium-sulfur compound used topically to reduce dandruff and associated scalp symptoms. The product name itself was built around the active ingredient, giving Selsun a pharmaceutical identity rather than the purely cosmetic positioning common to many later shampoo brands. A major turning point came in 1974, when Selsun Blue was introduced as an over-the-counter medicated shampoo containing 1% selenium sulfide. This made the brand more accessible to consumers and established Selsun Blue as the best-known mass-market expression of the Selsun name in North America. Prescription Selsun products and market-specific formulations continued to exist alongside the over-the-counter range, with some products using higher selenium-sulfide concentrations. Over time, the portfolio expanded beyond a single medicated formula to include moisturizing, conditioning, 2-in-1, daily-use and other hair-care variants. The brand remained associated with Abbott Laboratories for many years. In March 2002, Chattem announced the acquisition of worldwide rights, excluding India, to manufacture, sell and market Selsun Blue, which was marketed internationally as Selsun. The transaction also included related intellectual property and selected manufacturing equipment. Chattem’s subsequent filings described a program of investment in the brand’s packaging, advertising, media support, retail distribution and product range. The company credited these efforts with strengthening the performance of a brand that was already more than five decades old by the early 2000s. Chattem’s Selsun Blue portfolio included a medicated formula with a cooling-clean positioning, a moisturizing version containing aloe and moisturizers, a 2-in-1 product with a conditioning system and a formula designed for color-treated hair. Chattem also developed adjacent sub-lines. Selsun Salon was introduced in 2005 with pyrithione zinc and salon-oriented moisturizing and nutrient claims. Selsun Natural was introduced later with salicylic acid, botanicals, vitamins and a gentler-care proposition. These extensions showed how the brand sought to combine therapeutic dandruff control with the sensory and appearance benefits expected from mainstream hair care. Sanofi acquired Chattem in 2010. The acquisition placed Selsun Blue within Sanofi’s consumer-health portfolio alongside brands such as Gold Bond, Icy Hot, ACT and Cortizone-10. In the United States and some other Western markets, Selsun Blue was subsequently associated with Sanofi Consumer Healthcare. In 2025, Sanofi completed the separation of its consumer-health business into Opella, an independently managed company with outside investment from Clayton, Dubilier & Rice, Sanofi and Bpifrance. Selsun Blue is identified as part of the Opella-related portfolio in those markets. The brand’s ownership and operating model has differed by geography. In Indonesia, Selsun is operated by PT Rohto Laboratories Indonesia, a local company in the Rohto Pharmaceutical group. Rohto’s Indonesian business markets Selsun as a specialist anti-dandruff and scalp-care line. Rohto also states that Selsun has strong popularity across Asia, making the brand an important part of its international hair-care business. The Indonesian range has developed well beyond the original medicated shampoo concept. It includes Selsun Yellow, Gold, Blue, Blue 5, Yellow Double Impact, 7 Flowers, 7 Herbal, Scalp Care Purifying Shampoo, Hairfall Control Shampoo, Hairfall Control Serum and Nourishing Conditioner. The Indonesian portfolio combines selenium-sulfide-based dandruff control with cosmetic and scalp-care features. Depending on the variant, claims and ingredients address excess oil, cleansing, hair fall, moisture, softness, fragrance, botanical care, shine and manageability. The Scalp Care Purifying Shampoo uses piroctone olamine, climbazole and additional ingredients such as ectoin and saccharide isomerate, illustrating the brand’s movement toward broader scalp-health solutions rather than a single active-ingredient platform. In 2026, Selsun experienced a significant product-safety controversy in Indonesia. PT Rohto Laboratories Indonesia issued a public statement concerning Selsun 7 Flowers and Selsun 7 Herbal after differing test results relating to 1,4-dioxane contamination. The company apologized, instructed users to stop using the affected products, began a market withdrawal and said that more than 96% of the products had been recovered. It also stated that the affected batches would be destroyed, that consumers could seek product exchanges, and that new formulas had been developed and submitted for regulatory review. Rohto maintained that other Selsun shampoo variants were compliant and were not implicated by the issue. The episode became the most important recent regulatory event in the brand’s Indonesian history and resulted in a planned reformulation and relaunch of the two affected lines.

• 2026

  Selsun 7 Flowers and Selsun 7 Herbal are withdrawn in Indonesia

  [3]Official Statement on Selsun 7 Flowers and Selsun 7 Herbalrohto.co.id

  PT Rohto Laboratories Indonesia announces a withdrawal after differing test results concerning 1,4-dioxane contamination and begins replacement and reformulation actions.

• 2025

  Opella becomes independent from Sanofi

  [10]Opella launches as an independent companyopella.com

  Sanofi completes the sale of a controlling stake in its consumer-health business, creating Opella as an independent company that includes Selsun Blue in relevant markets.

• 2025

  Rohto expands the Indonesian Selsun scalp-care range

  [2]Rohto Laboratories Indonesia Hair Care Portfoliorohto.co.id

  Rohto Indonesia lists Scalp Care Purifying Shampoo, Hairfall Control Shampoo, Hairfall Control Serum, Yellow, Gold, Blue, Blue 5, Yellow Double Impact and Nourishing Conditioner in its local range.

• 2010

  Sanofi acquires Chattem

  [9]Sanofi 2010 Form 10-Ksec.gov

  Selsun Blue becomes part of Sanofi’s consumer-health portfolio through Sanofi’s acquisition of Chattem.

• 2007

  Selsun Natural is introduced

  [8]Chattem product portfolio filingsec.gov

  Chattem introduces Selsun Natural with salicylic acid, botanicals, vitamins and a gentler hair-care positioning.

• 2005

  Selsun Salon is introduced

  [8]Chattem product portfolio filingsec.gov

  Chattem launches Selsun Salon as a salon-oriented extension using pyrithione zinc and hair-care ingredients.

• 2002

  Chattem acquires Selsun Blue rights from Abbott

  [6]Chattem 2007 Form 10-Ksec.gov

  Chattem acquires worldwide rights, except in India, to manufacture, sell and market Selsun Blue and related intellectual property from Abbott Laboratories.

• 1974

  Selsun Blue becomes an over-the-counter medicated shampoo

  [1]About Selsun Blueselsunblue.ph

  Selsun Blue is introduced as an OTC medicated shampoo containing 1% selenium sulfide.

• 1953

  Selsun launches as a prescription anti-dandruff shampoo

  [1]About Selsun Blueselsunblue.ph

  Selsun is introduced in the United States as a prescription shampoo based on selenium sulfide.

Specialist anti-dandruff and scalp-health brand combining medicated efficacy with cosmetic hair-care benefits.

• Medicated anti-dandruff shampoo

  Selsun Yellow

  A core Indonesian Selsun variant positioned for stronger dandruff control. Rohto’s local materials identify the Selsun range as selenium-sulfide based, and the company specifically notes that Selsun Yellow contains 1.8% selenium sulfide and is not recommended for pregnant or breastfeeding users without appropriate professional advice. The product is positioned as a treatment-oriented shampoo rather than a purely cosmetic daily cleanser.

• Anti-dandruff shampoo · 1974

  Selsun Blue

  Selsun Blue is the internationally recognized OTC expression of the brand. The classic formulation is associated with 1% selenium sulfide and is designed to relieve dandruff symptoms while providing a clean scalp feel. In Indonesia, Selsun Blue is one of several Rohto-distributed variants and sits within a broader portfolio that combines medicated scalp care with cosmetic hair benefits.

• Anti-dandruff shampoo

  Selsun Blue 5

  Selsun Blue 5 is an Indonesian-market extension whose name refers to five intended consumer benefits: healthy, manageable, dandruff-free, clean and shiny hair. It broadens the Blue proposition from dandruff control toward everyday hair appearance and manageability while remaining within the specialist scalp-care range.

• Anti-dandruff shampoo

  Selsun Gold

  Selsun Gold is an Indonesian-market anti-dandruff shampoo positioned as a premium or enhanced-care variant within the local portfolio. Public product listings identify it as part of Rohto Indonesia’s Selsun range, although detailed formula and launch information are not consistently published on the corporate product page.

• Anti-dandruff shampoo

  Selsun Yellow Double Impact

  Selsun Yellow Double Impact is a local variant designed for consumers seeking dandruff control with additional hair-care benefits. Rohto Indonesia lists it among the brand’s active products and recommends it for normal-to-dry hair in its usage guidance. Detailed launch timing is not publicly stated on the cited product pages.

• Cosmetic anti-dandruff shampoo

  Selsun 7 Flowers

  Selsun 7 Flowers is a fragrance-oriented Indonesian variant associated with seven floral notes: peach blossom, violet, lily of the valley, rose, jasmine, white orchid and ylang-ylang. It was marketed as a softer, more cosmetic extension of the anti-dandruff range. In 2026, PT Rohto Laboratories Indonesia announced withdrawal of all batches following differing laboratory findings concerning 1,4-dioxane contamination and said a reformulated version was being prepared.

• Hairfall-control shampoo

  Selsun Scalp Care Hairfall Control Shampoo

  A scalp-care shampoo in Rohto Indonesia’s newer Selsun portfolio addressing hair-fall concerns alongside the brand’s broader scalp-health positioning. The corporate product listing confirms its inclusion in the Indonesian range, but the cited page does not provide a complete ingredient list, launch year or detailed clinical claims.

• Scalp serum

  Selsun Scalp Care Hairfall Control Serum

  A leave-on scalp-care serum designed for the hairfall-control segment. It extends Selsun beyond rinse-off dandruff shampoo into treatment-oriented scalp care. Rohto Indonesia lists the product in the official hair-care range, but detailed formula, launch date and efficacy data are not supplied in the cited public listing.

• Conditioner

  Selsun Nourishing Conditioner

  A companion conditioner intended to improve softness and manageability after shampooing. Rohto Indonesia recommends it for use after Selsun shampoo as part of a broader scalp and hair-care routine. It represents the brand’s effort to combine medicated dandruff care with conventional conditioning benefits.

• Salon-positioned anti-dandruff shampoo · 2005

  Selsun Salon

  A historical Chattem extension launched in 2005. Selsun Salon used pyrithione zinc together with moisturizers, vitamins and nutrients, targeting consumers who wanted dandruff control with more salon-oriented hair-care attributes. The line is documented in Chattem filings but is not confirmed as part of the current Indonesian portfolio.

• Gentle anti-dandruff shampoo · 2007

  Selsun Natural

  A historical Chattem extension introduced in fiscal 2007. Selsun Natural used salicylic acid and included botanicals, vitamins and moisturizers. The documented products included Arctic Energy and Island Breeze variants. The line illustrates the brand’s earlier attempt to address consumers seeking a less medicinal sensory proposition while retaining anti-dandruff functionality.

• 2026

  Withdrawal of Selsun 7 Flowers and Selsun 7 Herbal over 1,4-dioxane test findings

  PT Rohto Laboratories Indonesia announced the withdrawal of all batches of Selsun 7 Flowers and Selsun 7 Herbal after differing laboratory results concerning 1,4-dioxane contamination. The company stated that more than 96% of the products had been withdrawn, affected products would be destroyed, consumers could request exchanges and reformulated products were being prepared for regulatory review. Rohto said other Selsun shampoo variants were not affected according to its announcement.

  Source

Read more

• 2025Pondok Si Boncel social-support activity

  Indonesia

  Rohto Indonesia used Selsun Kids in a children’s coloring activity during a social-support event at Pondok Si Boncel orphanage in South Jakarta and distributed Selsun products to the institution.

  Outcome. The event supported community engagement and brand-linked corporate social responsibility; no commercial performance outcome was reported.

  Source
• 2002Selsun Blue brand revitalization program

  United States · international markets

  Following Chattem’s acquisition of Selsun Blue rights from Abbott, the company increased advertising, media, promotional support, distribution and product-development activity around the brand.

  Outcome. Chattem reported stronger brand performance and expanded appeal, but did not publish a complete campaign-level performance dataset in the cited filing.

  Source

• 2026

  Withdrawal and reformulation of Selsun 7 Flowers and Selsun 7 HerbalOther

  Background

  Rohto Indonesia reported differing laboratory results concerning 1,4-dioxane contamination in two Selsun variants and treated the issue as a product-safety and regulatory matter.

  Action taken

  The company withdrew all batches, advised users to stop using the affected products, offered exchanges, stated that recovered stock would be destroyed and developed new formulas for BPOM registration.

  Aftermath

  Rohto stated that more than 96% of affected products had been recovered and that relaunch was planned for the second half of 2026, subject to regulatory approval.

  Source

• 2025

  Opella separates from SanofiM&A

  Background

  Sanofi reorganized its consumer-health activities into a standalone company while retaining a minority stake after the transaction.

  Action taken

  Opella became independent with CD&R holding a controlling stake, Sanofi retaining 48.2% and Bpifrance holding 1.8%.

  Aftermath

  Selsun Blue remained associated with the Opella portfolio in relevant markets, while Indonesian Selsun operations continued under Rohto.

  Ownership structure. Sanofi consumer-health business → CD&R 50.0% controlling stake; Sanofi 48.2%; Bpifrance 1.8% (April 30, 2025)

  Source

• 2007

  Launch of Selsun NaturalProduct launch

  Background

  The brand sought to address consumers interested in botanical ingredients and a gentler sensory proposition while retaining anti-dandruff functionality.

  Action taken

  Chattem launched Selsun Natural products using salicylic acid, moisturizers, botanicals and vitamins.

  Aftermath

  The extension diversified the historical Selsun range, although its current status is not confirmed by the cited Indonesian sources.

  Source

• 2005

  Launch of Selsun SalonProduct launch

  Background

  Chattem sought to broaden Selsun beyond a strongly medicinal anti-dandruff image and appeal to consumers seeking salon-style hair-care benefits.

  Action taken

  Chattem introduced Selsun Salon with pyrithione zinc, moisturizers, vitamins and nutrients.

  Aftermath

  The launch created a documented salon-oriented extension, although current availability is not confirmed in the Indonesian portfolio.

  Source

• 2002

  Chattem acquires Selsun Blue rights from AbbottM&A

  Background

  Abbott had owned and marketed the long-established Selsun Blue brand. Chattem sought to expand its consumer-health portfolio through a medicated dandruff-shampoo brand with established recognition and international rights.

  Action taken

  Chattem acquired worldwide rights, except in India, to manufacture, sell and market Selsun Blue, together with related intellectual property and certain manufacturing equipment.

  Aftermath

  Chattem invested in advertising, packaging, distribution and product extensions, including Selsun Salon and Selsun Natural.

  Source

1. 1About Selsun Blueselsunblue.ph
2. 2Rohto Laboratories Indonesia Hair Care Portfoliorohto.co.id
3. 3Official Statement on Selsun 7 Flowers and Selsun 7 Herbalrohto.co.id
4. 4Selsun Scalp Care Purifying Shampoorohto.co.id
5. 5Rohto Pharmaceutical management strategy Q&Arohto.co.jp
6. 6Chattem 2007 Form 10-Ksec.gov
7. 7Chattem 2006 Form 10-Ksec.gov
8. 8Chattem product portfolio filingsec.gov
9. 9Sanofi 2010 Form 10-Ksec.gov
10. 10Opella launches as an independent companyopella.com
11. 11Rohto Indonesia contact informationrohto.co.id
12. 12Pondok Si Boncel social-support activityrohto.co.id